Pediatric inflammatory bowel disease

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 20

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. May 28, 2006; 12(20): 3204-3212
Published online May 28, 2006. doi: 10.3748/wjg.v12.i20.3204

Table 4 Medical management of IBD[4,12,19]

	CD	UC
Mild	Aminosalicylates Antibiotics	Aminosalicylates
Moderate	Corticosteroids→Aminosalicylates or AZA or 6-MP or Methotrexate	Corticosteroids→Aminosalicylates or AZA or 6-MP or Methotrexate
Severe	Corticosteroids→AZA or 6-MP or Methotrexate or Infliximab	Corticosteroids→AZA or 6-MP or Methotrexate or Cyclosporine
All cases	Nutritional support Monitor growth closely	Nutritional support Monitor growth closely

Citation: Diefenbach KA, Breuer CK. Pediatric inflammatory bowel disease. World J Gastroenterol 2006; 12(20): 3204-3212
URL: https://www.wjgnet.com/1007-9327/full/v12/i20/3204.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i20.3204

Diefenbach KA, Breuer CK. Pediatric inflammatory bowel disease. World J Gastroenterol 2006; 12(20): 3204-3212 [PMID: 16718840 DOI: 10.3748/wjg.v12.i20.3204]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.